Your session is about to expire
← Back to Search
Observational
Validation Set for Heart Failure (Home Predict Trial)
N/A
Waitlist Available
Led By Jeff Olgin, MD
Research Sponsored by University of California, San Francisco
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 90 day
Awards & highlights
No Placebo-Only Group
Summary
The HOME PREDICT HF study looks at new ways to predict hospitalizations for heart failure. We will use a set of devices at home and surveys to collect information about patient's health. This study uses the Eureka app, a new study app developed by the University of California, San Francisco. The study is designed to happen remotely, using this application on a patient's smartphone, so that is as convenient as possible to participate.
Eligible Conditions
- Heart Failure
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 90 day
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~90 day
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Heart Failure Hospitalization/ ED Visit
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Group I: Validation SetExperimental Treatment1 Intervention
n = 167
Group II: Training SetExperimental Treatment1 Intervention
n = 333
Find a Location
Who is running the clinical trial?
University of California, San FranciscoLead Sponsor
2,584 Previous Clinical Trials
15,084,123 Total Patients Enrolled
23 Trials studying Heart Failure
54,531 Patients Enrolled for Heart Failure
MYIA Labs, Inc.UNKNOWN
1 Previous Clinical Trials
165 Total Patients Enrolled
1 Trials studying Heart Failure
165 Patients Enrolled for Heart Failure
Jeff Olgin, MDPrincipal InvestigatorUniversity of California, San Francisco
Share this study with friends
Copy Link
Messenger